3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
10
Phase 2
6
Phase 1/2
3
Phase 3
2
Phase NA
1
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Pancreatic Neoplasms
3
Glioblastoma
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Squamous Cell Carcinoma of Head and Neck
1
Oligodendroglioma
1
Glioma
1
Childhood Brain Neoplasm
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Astrocytoma
1
Acidemia, isovaleric
1
Interventions
Magnetic Resonance Spectroscopy
7
Temozolomide
6
Radiotherapy
6
fluciclovine F-18
4
Topotecan
4
fluorodopa F 18
3
Biopsy
3
niraparib
2
abemaciclib
2
Standard of Care
2
Specimen Handling
2
Pemetrexed
2
Ketoconazole
2
ulixertinib
1
temsirolimus
1
ribociclib
1
posaconazole
1
poly ICLC
1
pitavastatin
1
pembrolizumab
1
orludodstat
1
lorlatinib
1
larotrectinib
1
infigratinib
1
fisetin
1
fimepinostat
1
evolocumab
1
clevudine
1
X-Rays
1
Watchful Waiting
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Glioma
×
Surgical Procedures, Operative
×
Clear all
NCT05577416
2026-03-18
AB-218-IIT-201
Melbourne Health
Phase EARLY_PHASE1
Completed
14 enrolled